Prrt Sequencing And The Future Of Neuroendocrine Tumor Treatments With Jonathan Strosberg, Md

PRRT Sequencing and the Future of Neuroendocrine Tumor Treatments with Jonathan Strosberg, MD

Carcinoid Cancer Foundation

PRRT (Peptide Receptor Radionuclide Therapy) with Jonathan Strosberg, MD

Carcinoid Cancer Foundation

Who is a Good Candidate for PRRT (Peptide Receptor Radionuclide Therapy) with Jonathan Strosberg, MD

Carcinoid Cancer Foundation

"PRRT: What We Know, Special Considerations & Clinical Trials" with Dr. Strosberg • Jan 11, 2024

Peptide Receptor Radionuclide Therapy (PRRT)

Carcinoid Cancer Foundation

NET Cancer Questions with Jonathan Strosberg, MD

Carcinoid Cancer Foundation

Treatment Sequencing for NETs: Where Does PRRT Fit In? Chandrasekharan

Dr. Strosberg on Future of 177Lu-Dotatate Therapy in Neuroendocrine Tumors

Improving PRRT for Neuroendocrine Tumors (NETs)

Dr. Strosberg on FDA Approval of Lutathera for GEP-NETs

How PRRT Can Improve Care for Neuroendocrine Tumor Patients

Dr. Strosberg on Pasireotide for Neuroendocrine Tumors

Dr. Strosberg on Challenges in the Treatment of Neuroendocrine Tumors

NETWise Episode 4: Nuclear Medicine for NETs: PRRT- (See Episode 28 for the Updated Version)

Dr. Strosberg Discusses Trials in Neuroendocrine Tumors

Neuroendocrine Tumor Treatments with Richard RP Warner, MD

Carcinoid Cancer Foundation

Treatments for Neuroendocrine Tumors

University Hospitals

Sequencing Considerations in Advanced Pancreatic Neuroendocrine Tumors

NETTER-1 update: 177Lu-DOTATATE in patients with midgut neuroendocrine tumors

LACNETS Webinar: "Sequencing of Neuroendocrine Tumor Treatments" with Dr. Eric Liu